Lapatinib Tablets

Lapatinib Tablets Specification

Indication
Treatment of advanced or metastatic breast cancer

Salt Composition
Lapatinib Ditosylate

Origin
Pharmaceutical

Dosage Form
Tablets

Ingredients
Lapatinib Ditosylate, Excipients

Application
Oncology, Breast Cancer Therapy

Storage Instructions
Store at room temperature, 20°C to 25°C (68°F to 77°F); Protect from moisture.

Shelf Life
24 to 36 months

Registration Status
WHO GMP, ISO Certified manufacturing

Brand Name Examples
Tykerb, Tyverb

Prescription Required
Yes

Strength
250 mg per tablet

Contraindications
Hypersensitivity to Lapatinib or any component

ATC Code
L01XE07

Administration Route
Oral

Packaging Size
30 tablets per box, blister pack

About Lapatinib Tablets

Lepatinib:-

Lapatinib is used with capecitabine (Xeloda) to treat a certain type of advanced breast cancer in people who have already been treated with other chemotherapy medications. Lapatinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells.

Lapatinib comes as a tablet to take by mouth. It is usually taken once a day, at least 1 hour before or 1 hour after a meal. Take all of the tablets for your daily dose at one time each day; do not divide the tablets to take as separate doses. Take lapatinib at around the same time every day.

Precision Therapy for Breast Cancer

Lapatinib Tablets offer a targeted approach in treating advanced and metastatic breast cancer. Acting as a dual tyrosine kinase inhibitor, Lapatinib effectively interrupts critical pathways responsible for tumor growth. This specialized action provides improved management options for patients whose cancer has progressed despite previous treatments, making it a valuable addition to oncologic therapies.

Trust in Quality and Compliance

Manufactured in facilities adhering to WHO GMP and ISO standards, Lapatinib Tablets guarantee high-quality and reliable efficacy. Every batch is produced under stringent quality checks to ensure patient safety and consistent therapeutic outcomes. This focus on quality assurance reinforces trust among dealers, distributors, and healthcare providers worldwide.

FAQs of Lapatinib Tablets:

Q: How should Lapatinib Tablets (250 mg) be taken for best results?

A: Lapatinib Tablets are administered orally as directed by a healthcare professional, often as part of a treatment regimen for advanced or metastatic breast cancer. Dose and duration are individualized, so follow your doctors instructions closely for optimal results.

Q: What are the benefits of using Lapatinib Tablets in breast cancer therapy?

A: Lapatinib Tablets target specific proteins that drive tumor growth, offering a more focused approach to treating certain breast cancers. This can help slow disease progression and improve outcomes, especially in cases resistant to other therapies.

Q: When is Lapatinib indicated in oncology treatment?

A: Lapatinib is indicated for patients with advanced or metastatic breast cancer, typically after other treatments have become less effective. Your oncologist will determine the appropriate timing based on your specific condition.

Q: Where are Lapatinib Tablets manufactured and what certifications do they have?

A: These tablets are produced in India at facilities certified by WHO GMP and ISO standards, ensuring high-quality manufacturing practices and global compliance.

Q: What is the storage instruction for Lapatinib Tablets?

A: Store the tablets at room temperature, between 20C and 25C (68F and 77F), and protect them from moisture. Following storage guidelines helps maintain the medications effectiveness throughout its shelf life.

Q: What are the contraindications for Lapatinib Tablets?

A: Lapatinib should not be used by individuals with hypersensitivity to Lapatinib or any tablet component. Always inform your doctor of any allergies or adverse reactions to medications before starting treatment.

Get Latest Price